Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566) Research & Development: HK$136 Mil (TTM As of Dec. 2025)


HKSE:02566 Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd HKSE:02566
20 GF Score
Price HK$5.79
! 1 Warning Sign
View Full Analysis

What is Hangzhou Jiuyuan Genetic Biopharmaceutical Co Research & Development?

Hangzhou Jiuyuan Genetic Biopharmaceutical Co HKSE:02566 -2.03% 20 Research & Development is HK$136 Mil as of Dec. 2025. GuruFocus rates HKSE:02566 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Research & Development for the six months ended in Dec. 2025 was HK$82 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$136 Mil.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co  (HKSE:02566) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Research & Development Related Terms

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Research & Development Historical Data

* Premium members only.

The historical data trend for Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Research & Development Chart

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
162.40 176.79 139.74 116.27 136.61

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial 68.37 40.14 76.46 54.25 81.79
HKSE:02566
20GF Score
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd HKSE:02566
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$136 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$136 Mil mean?
Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566) has a Research & Development of HK$136 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Hangzhou Jiuyuan Genetic Biopharmaceutical Co and its competitors.
Is Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Research & Development too high?
Hangzhou Jiuyuan Genetic Biopharmaceutical Co's current Research & Development is HK$136 Mil. Overall, Hangzhou Jiuyuan Genetic Biopharmaceutical Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Research & Development compare to VRTX and REGN?
Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Research & Development of HK$136 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Hangzhou Jiuyuan Genetic Biopharmaceutical Co and its competitors. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's current Research & Development is HK$136 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Jiuyuan Genetic Biopharmaceutical Co stock overvalued right now?
Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566) has a current Research & Development of HK$136 Mil. The current Research & Development is HK$136 Mil. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566), the current Research & Development is HK$136 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Business Description

Address No. 23, Eighth Street, Baiyang Street, Qiantang District, Zhejiang Province, Hangzhou, CHN
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd is a biopharmaceutical company in China. It is engaged in the research & development, manufacturing, and commercialization of biopharmaceutical products and medical devices. The company focuses on four large and fast-growing therapeutic areas: orthopedics, metabolic diseases, oncology, and hematology. Centered around these therapeutic areas, it has built a diversified product portfolio comprising several marketed products, such as Jilifen, Jijufen, Jiouting, Yinuojia, Guyoudao, etc., and has several product candidates under development, such as JY54, JY23, JY47, JY56, JY29-2, etc., targeting various indications. Geographically, the company generates maximum revenue from the Chinese Mainland, and the rest from other countries.
20GF Score

Get the complete analysis for HKSE:02566

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$5.79
Price